Kaneka invests in AB-Biotics SA biotech company

Kaneka has concluded a license agreement with ABB to give Kaneka the rights for production and sales of ABB's products in the US, Canada and Japan.
Kaneka has concluded a license agreement with ABB to give Kaneka the rights for production and sales of ABB's products in the US, Canada and Japan.

Related tags: Kaneka, Lactic acid bacteria, Probiotics

Japanese company Kaneka Corporation has acquired a 34.8% share of AB-Biotics (ABB), a Spanish biotech company focusing on research, development, and distribution of its own products using lactic acid bacteria.